The Boston-based telehealth vendor beat Wall Street expectations on earnings but missed on revenue, which rose 7% year over year to total $57.6 million.
Original source: https://www.healthcaredive.com/news/amwell-growth-slows-in-q1-amid-investor-fears-of-telehealth-deceleration/600087/